Replies to post #17498 on General Stock Ideas

[ombowstring]

>>>>> The data one the mild to moderate will be ready in the second half of the month, at least that is what I think. I doubt the severe data will be available this month at all. Even if it is ready IL6 blockers have already been studied in severe covid 19 patients and they did not work.<<

This is a false statement by spiritof76. Leronlimab is a CCR5 inhibitor.